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ABSTRACT The low-density lipoprotein (LDL) receptor
plays a central role in mammalian cholesterol metabolism,
clearing lipoproteins which bear apolipoproteins E and B-100
from plasma. Mutations in this molecule are associated with
familial hypercholesterolemia, a condition which leads to an
elevated plasma cholesterol concentration and accelerated
atherosclerosis. The N-terminal segment of the LDL receptor
contains a heptad of cysteine-rich repeats that bind the
lipoproteins. Similar repeats are present in related receptors,
including the very low-density lipoprotein receptor and the
LDL receptor-related protein/C!2-macroglobulin receptor,
and in proteins which are functionally unrelated, such as the
C9 component of complement. The first repeat of the human
LDL receptor has been expressed in Escherichia coli as a
glutathione S-transferase fusion protein, and the cleaved and
purified receptor module has been shown to fold to a single,
fully oxidized form that is recognized by the monoclonal
antibody IgG-C7 in the presence of calcium ions. The three-
dimensional structure of this module has been determined by
two-dimensional NMR spectroscopy and shown to consist of
a (3-hairpin structure, followed by a series of I3 turns. Many
of the side chains of the acidic residues, including the highly
conserved Ser-Asp-Glu triad, are clustered on one face of the
module. To our knowledge, this structure has not previously
been described in any other protein and may represent a
structural paradigm both for the other modules in the LDL
receptor and for the homologous domains of several other
proteins. Calcium ions had only minor effects on the CD
spectrum and no effect on the 'H NMR spectrum of the repeat,
suggesting that they induce no significant conformational
change.
The low-density lipoprotein (LDL) receptor regulates the
concentration of plasma LDL and cholesterol by internalizing
apolipoprotein (apo) B-100- and apoE-containing lipoproteins
(1). These apolipoproteins are present in a variety of lipopro-
teins, including very low-density lipoprotein (VLDL) and
intermediate-density lipoprotein; however, apoB-100 is the
only protein constituent of LDL (2). Mutations in the LDL
receptor are associated with familial hypercholesterolemia (3),
in which the number of functional receptors is reduced,
resulting in elevated concentrations of plasma LDL and cho-
lesterol and leading to accelerated atherosclerosis (4). Five
functionally discrete domains are present in the LDL receptor,
including an epidermal growth factor-like domain and a
heptad of cysteine-rich repeats that form the binding site for
LDL (5). Different combinations of these repeats are involved
in binding apo E and apoB-100 (6). Deletion of a single
cysteine-rich repeat can alter the binding specificity of the
receptor (7).
There is 40-50% sequence similarity between the repeats in
the human LDL receptor ligand-binding domain, with each
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containing six cysteine residues and a highly conserved cluster
of negatively charged amino acids (5). The lysine and arginine
residues present in apoB-100 and apoE have been postulated
to interact with these negatively charged amino acids (5, 8). In
addition, it has been suggested that calcium ions interact with
the repeats, as ligand binding is calcium dependent (9). The
N-terminal cysteine-rich repeat of the LDL receptor (LB1) is
not involved in binding the ligands; however, it appears to
contain a calcium-binding site, as it is recognized by mono-
clonal antibody IgG-C7 only in the presence of calcium ions
(9-11). This antibody was raised against the intact receptor
and is conformation specific, as binding is abolished when the
disulfide bonds of the repeat are reduced (10, 11).
A number of other proteins also contain these repeats,
including the VLDL receptor (12), the LDL receptor-related
protein/a2-macroglobulin receptor (13), renal glycoprotein
gp330 (14), the C9 component of complement (15), the linker
protein of earthworm hemoglobin (16), and a receptor for
subgroup A Rous sarcoma virus (17) (Fig. 1A). Within these
repeats, the cysteine residues and C-terminal acidic residues
are still highly conserved. As the repeats are present in a
variety of unrelated proteins, it has been suggested that they
are of ancient origin and may have been incorporated by exon
shuffling (16).
LB1 has been expressed in Escherichia coli as a cleavable
glutathione S-transferase fusion protein. Although LB1 is not
involved in binding either ligand, it was initially chosen for
study because of the availability of IgG-C7, which provides the
best available assay for adoption of a native structure by the
expressed protein. Given the level of amino acid sequence
similarity between the repeats, it is likely that the first repeat
will serve as a structural paradigm for the others. Thus, the
three-dimensional structure of the recombinant LB1 peptide
has been determined by NMR spectroscopy and shown to
contain a previously undescribed structural motif comprising
a short 3-sheet segment at the N-terminal end, followed by a
series of 13-turns. The protein has a small core of hydrophobic
residues and one face that bears many of the acidic side chains.
The effect of calcium ions on the structure was also examined.§
MATERIALS AND METHODS
Expression and Purification. The cDNA of LBI was am-
plified by PCR and cloned by insertion into the expression
vector pGEX-2T (20). Recombinant LB1 was expressed as a
thrombin-cleavable glutathione S-transferase fusion protein in
E. coli by using a 15-liter Chemap (Mannedorf, Switzerland)
Abbreviations: apo, apolipoprotein; LDL, low-density lipoprotein;
LBI, N-terminal cysteine-rich repeat of the LDL receptor; NOE,
nuclear Overhauser enhancement; VLDL, very low-density lipopro-
tein.
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fermentor. Following glutathione-agarose-affinity chromatog-
raphy (20), the glutathione-agarose-bound glutathione S-
transferase fusion protein was reduced by incubation with 1
mM dithiothreitol for 1 h at 37°C and cleaved with bovine
thrombin (5 units per mg of fusion protein) to release recom-
binant LB1. Cleavage of the fusion protein with thrombin
resulted in an extra two residues (glycine and serine) on the N
terminus of LB1. In addition, the first four residues of the
second repeat have also been included (Fig. 1B). The peptide
was oxidized in the presence of 3 mM reduced and 0.3 mM
oxidized glutathione and subsequently purified by reverse-
phase HPLC on a C18 8 mm x 100 mm Waters Radial-Pak
column. Gradients of 0.1% aqueous trifluoroacetic acid and
0.1% trifluoroacetic acid in acetonitrile were employed with
detection at 214 and 280 nm. Mass analysis was performed on
a Sciex (Thornhill, ON, Canada) triple quadrupole mass
spectrometer by using electrospray sample ionization. An
estimate of free thiols in a 100-,ug sample of HPLC-purified
LB1 was obtained by using Ellman's reagent, 5,5'-dithiobis(2-
nitrobenzoic acid) (21).
Monoclonal Antibody Analysis. HPLC-purified LB1 (4 ,ug)
was dotted onto a 0.2-,um pore size nitrocellulose membrane.
The membrane was baked for 8 h in a vacuum oven at 80°C and
blocked for 1 h in Tris-buffered saline (20 mM Tris-HCl, pH
7.5/500 mM NaCl), which contained 5% (wt/vol) nonfat skim
milk. Membranes were incubated with IgG-C7 in the presence
or absence of 2 mM Ca2 . Incubations in the absence of Ca2+
also contained 30 mM EDTA. Mouse monoclonal antibody
IgG-C7 was prepared by injecting 6- to 11-week-old, BALB/c
mice intraperitoneally with the IgG-C7-producing hybridoma
CRL 1691, as described (22). Signals were detected by en-
hanced chemiluminescence substrate (Amersham) according
to the manufacturer's instructions and exposed to x-ray film
(Agfa) for time periods ranging from 5 s to 10 min.
Sedimentation Equilibrium. Sedimentation equilibrium ex-
periments were performed on LB1 at 20°C by using a Beckman
Optima XLA analytical ultracentrifuge. A pathlength of 2.51
mm was used with a homemade aluminium-filled epon cen-
terpiece. The angular velocity was 60,000 rpm and the absor-
bance throughout the cell was recorded at 280 nm at 3-h
intervals until equilibrium was attained. The molecular weight
was determined by using a calculated partial specific volume of
0.687 ml/g.
CD Spectroscopy. Spectra were recorded on an Aviv Asso-
ciates (Lakewood, NJ) model 62 DS spectrometer over the
wavelength range of 260-190 nm and using a 0.1-mm path-
length cell, a bandwidth of 1.0 nm, a response time of 2 s, a scan
rate of 20 nm-min-1, and averaging over eight scans. The
concentration of LB1 was 45 ,uM, and the pH was adjusted to
3.9 and 6.9 with 1 M NaOH. In addition, the effect of Ca2+ on
the CD spectra was examined by adding a stoichiometric and
3-fold molar excess of calcium chloride.
NMR Spectroscopy. LB1 was dissolved in 10% 2H20, pH 3.9
or pH 6.3, at a concentration of approximately 1 mM. For
experiments in 2H20, the sample was lyophilized and dissolved
FIG. 1. Comparison of the amino acid sequences of
LB1 from human (18) and Xenopus (19) LDL receptor
(LDLR), human VLDL receptor (VLDLR) (12), the C9
component of complement (15), earthworm hemoglobin
(Hb) (16), LDL receptor-related protein/a2 macroglob-
ulin receptor (LRP) (13), and renal glycoprotein gp330
(14) (A). Amino acids that are conserved at each site are
boxed. The consensus sequence is shown at the bottom.
(B) Sequence and disulfide connectivities of the protein
used in theNMR studies. The N-terminal Gly-Ser results
from the inclusion of a thrombin cleavage site in the
fusion protein; these residues were not included in the
structures depicted in Fig. 6 or in the numbering system
used in the text.
in 99.96% 2H20 (Wilmad, Buena, NY). The effect of calcium
ions on the NMR spectra was also examined by adding a 3-fold
molar excess of CaCl2. 'H NMR spectra were recorded on
Bruker (Billerica, CA) model AMX 500 or ARX 500 spec-
trometers. Standard pulse sequences were used to obtain
double quantum filtered correlated spectroscopy (DQF
COSY) (23), total correlated spectroscopy (TOCSY) (24)
(mixing times 80 and 100 ms), exclusive correlation spectros-
copy (E.COSY) (25) and nuclear Overhauser enhancement
(NOE) spectroscopy (NOESY) (26) (mixing times 65, 200, and
250 ms) spectra. The water signal was suppressed by low-power
irradiation during the relaxation delay (2 s) and during the
mixing time of the NOESY experiments. Two-dimensional
experiments were generally collected into 4096 data points
with 512 t1 increments of 32-64 scans. Five TOCSY spectra
collected with 16 scans and 128 t, increments and a relaxation
delay of 1 s were interleaved with one-dimensional spectra for
the 2H20 exchange experiments. Spectra were processed by
using UXNMR (Bruker software). Generally, both dimensions
were multiplied by a sine-bell function shifted by 90°, and a
polynomial baseline correction was applied to selected regions.
Spectra were recorded at pH 3.9 and 6.3, over a range of
temperatures (290, 303, and 310 K) to enable assignment of
overlapped resonances. Chemical shifts were referenced to
external 3-trimethylsilylpropionic acid-d4 (Fluka).
Structure Determination. A set of 55 structures was gener-
ated using 427 NOE distance restraints consisting of 200
intraresidue, 89 sequential, 64 short-range (c5 residues), and
74 long-range (>5 residues) NOEs, which were classified as
strong, medium, or weak and given upper bounds of 2.7, 3.5,
and 5.0 A, respectively. Peak volumes were measured in an
NOESY spectrum recorded with a mixing time of 65 ms by
using the EASY program (27) and used to derive distance
restraints. Standard values of pseudoatom corrections were
added (28). In addition, 1.5 A was added to the upper distance
limits for methyl protons, and degenerate methyl and meth-
ylene proton distances were multiplied by 1.2 and 1.1, respec-
tively. The N-terminal glycine and serine had no distance
restraints and were not included in the structure calculations.
Torsional restraints were applied to seven 4 angles with
bounds of -120° + 30° for angles with 3JHN-Ha coupling
constants >9 Hz. An E.COSY experiment was used to esti-
mate 3JH~-Hp coupling constants which were used in conjunc-
tion with NOE intensities to derive four Xl restraints.
The structures were generated on a Sun Microsystems
(Mountain View, CA) model SPARCstation2 with ab initio
simulated annealing using the XPLOR program (Version 3.1;
Molecular Simulations, Waltham, MA), starting with a tem-
plate and random 4 and 4' angles. The simulated annealing
protocol involved an initial energy minimization in a geometric
force field (kb.nd = 500 kcal.mol- .A-2, kang and kimproper = 500
kcal.mol-l rad-2) with a purely repulsive, nonbonded energy
term (repel = 1, weight = 0.002), a soft square-well NOE-
restraining function (kNoE = 50 kcal-mol-I.A-2, asymptote =
0.1), and an energy constant of 5 kcal-mol-lrad-2 for the
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FIG. 2. LB1 was recognized by antibody IgG-C7 that binds to this
repeat in the intact receptor but not to the unfolded polypeptide (10,
11). This immunoblot shows that the expressed LB1 binds the antibody
only in the presence of calcium ions, just like the intact receptor.
experimental dihedral angle restraints. A total of 30 ps of high
temperature (1000 K) dynamics was carried out in two stages
in which the van der Waals radii and weighting terms and NOE
asymptote were varied. In the first 20 ps of dynamics, the
weightings used were as follows: van der Waals, 0.002; angle,
0.4; and improper terms, 0.1. These weightings and the NOE
asymptote were increased to 1 during the final 10 ps of
high-temperature dynamics. Structures were then cooled to
100 K over 15 ps, during which the van der Waals radii and
weighting were gradually changed to give final values of 0.8 and
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FIG. 3. CD spectra of LB1, 45 ,uM at pH 3.9 (dashed line), pH 6.9
(thin line), and pH 6.9 in the presence of 135 ,uM CaCl2 (thick line).
A stoichiometric or 3-fold molar excess of calcium chloride was added
to the sample at pH 6.9. The stoichiometric concentration of calcium
chloride had no effect (results not shown).
4.0, respectively. The energy constant used for the experimen-
tal dihedral angle restraints was increased to 200 kcal-
mol-' rad-2 for this step. Refinement of the structures was
achieved with a second round of simulated annealing from
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FIG. 4. Overview of short-range NOEs observed for LB1. The thickness of the lines corresponds to the intensity of NOEs. The filled circles
indicate amide protons present 2.5 h after LB1 was dissolved in 2H2O.
45
L S V T
m
6336 Biochemistry: Daly et aL
Proc. Natl. Acad. Sci. USA 92 (1995) 6337
15-~ ~ ~ ~
25-35 -U1
o3 a
45
5 iS 25 35 45
Residue number
FIG. 5. Diagonal plot of the interresidue NOE distance restraints.
The filled squares represent restraints involving at least one backbone
atom, and the open squares indicate restraints involving only side-
chain atoms.
1000 K to 100 K over 10 ps by using a square-well NOE-
restraining function (kNoE = 50 kcal.mol-l.A-2) and an energy
constant of 200 kcal mol-1rad-2 for the experimental dihedral
angle restraints. During the initial structure calculations, the
disulfide connectivities were not explicitly defined; however,
these calculations resulted in an unambiguous assignment of
the disulfide bonds, which were then included as conforma-
tional restraints in the final subsequent simulated annealing
and refinement calculations.
RESULTS AND DISCUSSION
Purified, oxidized LB1 migrates as a single symmetrical peak
on isocratic HPLC (24:1 CH3CN), indicating that only one of
the possible disulfide bonding patterns is present. It appears to
be fully oxidized as it does not react with Ellman's reagent,
iodoacetamide, or vinylpyridine in the presence of denaturants
(S. Bieri, J.T.D., N.L.D., R.S., and P.A.K., unpublished data).
The conformation-specific antibody, IgG-C7, recognizes pu-
rified LB1, indicating that it is correctly folded (Fig. 2).
The CD spectra of LB1 in aqueous solution are indicative of
a lack of regular secondary structure (Fig. 3). Minor changes
occur in the CD spectra upon the addition of CaCl2; however,
no change was observed in the NMR spectra recorded in the
presence of a 3-fold molar excess of CaC12. There is evidence
suggesting that LB1 binds calcium (9); however, under the
present conditions, calcium ions do not appear to induce a
significant conformational change. Similarly, no substantial
conformational changes were apparent in the NMR spectra
over the pH range 3.9-6.9.
The resonance assignments and interproton distance con-
straints were obtained by conventional methods (29). Several
a chemical shifts were below the water resonance; however,
changing the pH and temperature shifted the overlapped
resonances sufficiently to allow assignment of resonances to all
residues except the N-terminal glycine. Although the CD
spectra indicated the absence of ordered secondary structure,
the amide shifts were well dispersed over 3 ppm, showing the
presence of persistent three-dimensional structure. Structures
were calculated from the spectra recorded at pH 6.3 and 303
K. The NOE restraints used in the final calculations are
depicted in Figs. 4 and 5. The slowly exchanging amide proton
resonances are also presented in Fig. 4.
Initial structures derived from NMR data without including
the disulfide bonds as structural restraints revealed the follow-
FIG. 6. Stereoview of the backbone (N, Co, C') of 20 NMR-derived structures (residues 6-42) of the N-terminal LDL receptor ligand-binding
repeat, superimposed over residues 11-42. The disulfide bonds are presented in orange/yellow (Upper). The side chains of acidic residues (Asp-15,
Asp-26, Glu-30, Asp-33, Asp-36, Glu-37, and Glu-40) are highlighted in green, aromatic residues in red, Ile-19 and Val-24 in blue, and Lys side
chains in pink (Lower).
Biochemistry: Daly et al
Proc. Natl. Acad. Sci. USA 92 (1995)
ing pairings: Cys-6C`ys-18, Cy§s-13'Cys-31, and Cys-25 Cys-42.
These connectivities were confirmed by a combination of
partial reduction and alkylation and trypsin or proteinase K
proteolysis, coupled with N-terminal sequencing and electro-
spray mass spectrometry (S. Bieri, J.T.D., N.L.D., R.S., and
P.A.K., unpublished data).
In the final set of 55 structures generated with disulfide bond
restraints, the 20 lowest-energy structures were selected for
analysis. In these structures no NOE distance restraint was
violated by >0.4 A, and no angle restraints were violated by
>40. The root-mean-square deviation (RMSD) values from
the experimental restraints and idealized geometry were as
follows: NOE restraints, 0.05 + 0.02 A; dihedral restraints,
0.850 + 0.20; bonds, 0.0045 ± 0.0002 A; angles, 0.500 ± 0.040;
and improper angles, 0.340 ± 0.03°. Energies corresponding to
NOE restraints and dihedral restraints were 65 ± 4 kcal mol 1
and 0.43 ± 0.2 kcal mol-1, respectively. The RMSD about the
mean coordinate positions for residues Phe-11 to Cys-42 was
0.65 ± 0.14 A for heavy atoms and 1.11 ± 0.12 A for all atoms
(Fig. 6 Upper).
Inspection of the low-energy structures revealed that resi-
dues Glu-10 to Ser-20 form a class three, three-residue ,B-hair-
pin structure (30), within which Phe-11, Asn-13, Lys-17, and
Ile-19 have amide protons that exchange slowly and therefore
appear to be involved in hydrogen bonds. This is followed by
three f3 turns (31) involving residues Tyr-21 to Val-24, Ser-35
to Ser-38, and Gln-39 to Cys-42. The amide protons of residues
Val-24 and Ser-38 exchange slowly and thus also appear to be
involved in hydrogen bonds; however, Cys-42 is not. Additional
turns are present from residues Cys-25 to Ser-28 and Cys-31 to
Gly-34; however, these regions of the molecule are less well
defined. The N- and C-terminal segments have few constraints
and are thus poorly defined.
The residues Phe-11 and Ile-19, which are completely con-
served between repeats in the LDL receptor, together with
Tyr-21, Trp-23, and Val-24, form a hydrophobic cluster that is
partly solvent-exposed. Despite this exposure of the hydro-
phobic core, the peptide showed no sign of aggregation at near
millimolar concentrations in sedimentation equilibrium exper-
iments, which gave Mr = 5200 ± 200, or in the NMR spectra.
The content of hydrophobic residues in LB1 is far lower than
that in most globular proteins, and the core is consequently
small. The side chains of the remaining hydrophobic residues,
Leu-43 and Val-45, have poorly defined positions in the
isolated repeat but would normally be present in the second
cysteine-rich repeat of the LDL receptor.
The level of homology within the LDL receptors of several
species (19) is higher than between the proteins listed in Fig.
1A. A consensus sequence of A-----C--RNEF-C-D--GKCI--
KWVCDGS-EC-DGSDE--ETC (with some minor and gener-
ally conservative substitutions) spans the LB1 modules of
human, rat, rabbit, hamster, and Xenopus, and a sequence of
C-----F-C------CI-----C----(D/E)C---SDE----C is common to
the seven repeats of the human receptor. The degree of
conservation is higher across species for a given repeat than
between repeats for a given species, suggesting distinct func-
tions for the individual modules. However, in both of these
consensus sequences, there is a cluster of acidic residues in the
C-terminal half, which for LB1 includes Asp-26, Glu-30,
Asp-33, Asp-36, Glu-37, and Glu-40. The carboxylates of
Asp-26 and Glu-30 and of Asp-15 and Asp-33 lie close to each
other; however, the latter pair of acidic residues are also in the
vicinity of the basic side chain of Lys-17. In contrast, the
carboxylate of Asp-36 is buried. The reason for the nonin-
volvement of LB1 in binding is unknown but may be related to
the burying of the Asp-36 residue side chain, which is highly
conserved and is thought to interact with the lipoproteins.
Asp-15, Asp-26, Glu-30, Asp-33, and Glu-37 all appear on one
face of the module, as shown in Fig. 6 Lower. This pattern,
if repeated in the other domains, would form an appropriately
charged surface for interaction with the basic residues of apo
B-100 and apoE (5, 8).
A computerized search of structures lodged with the Protein
Data Bank detected no other proteins with a comparable
topology (32). Those having the closest structural homology
had root-mean-square deviations of over 3.5 A for the a-car-
bon atoms, matched only by aligning several short nonsequen-
tial segments, and bore no similarity in amino acid sequence to
LB1. Thus, the topology of this module appears to be distinct
from any other in the protein data base and is likely to be
mimicked within the LDL receptor and in the other diverse
proteins containing these cysteine-rich repeats.
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